UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Nature communications, 2018-08, Vol.9 (1), p.3196-15, Article 3196

2018

Volltextzugriff (PDF)

Preoperative risk assessment does not allow to predict root filling length using machine learning: A longitudinal study

Journal of dentistry, 2023-01, Vol.128, p.104378-104378, Article 104378

2023

Volltextzugriff (PDF)

Innovative Clinical Trials: The LUNG-MAP Study

Clinical pharmacology and therapeutics, 2015-05, Vol.97 (5), p.488-491

2015

Volltextzugriff (PDF)

EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancer

Annals of oncology, 2014-10, Vol.25 (10), p.1941-1948

2014

Volltextzugriff (PDF)

A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2003, Vol.39 (1), p.55-61

2003

Volltextzugriff (PDF)

Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours

British journal of cancer, 2012-10, Vol.107 (8), p.1277-1285

2012

Volltextzugriff (PDF)

Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours

British journal of cancer, 2012-10, Vol.107 (8), p.1268-1276

2012

Volltextzugriff (PDF)

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Annals of oncology, 2019-08, Vol.30 (8), p.1311-1320

2019

Volltextzugriff (PDF)

A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors

Cancer chemotherapy and pharmacology, 2012, Vol.69 (1), p.165-172

2012

Volltextzugriff (PDF)

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

Annals of oncology, 2017-01, Vol.28 (1), p.75-82

2017

Volltextzugriff (PDF)

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial

Annals of oncology, 2019-02, Vol.30 (2), p.281-289

2019

Volltextzugriff (PDF)

Surrogate markers in antiangiogenesis clinical trials

British journal of cancer, 2003-07, Vol.89 (1), p.8-14

2003

Volltextzugriff (PDF)

Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC

Annals of oncology, 2023-04, Vol.34 (4), p.377-388

2023

Volltextzugriff (PDF)

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function

Annals of oncology, 2017-01, Vol.28 (1), p.83-89

2017

Volltextzugriff (PDF)

Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis

Cancer research (Chicago, Ill.), 2000-09, Vol.60 (17), p.4959-4967

2000

Volltextzugriff (PDF)

Role of novel targeted therapies in the clinic

British journal of cancer, 2005-06, Vol.92 (S1), p.S21-S27

Herbst, R S

2005

Volltextzugriff (PDF)

Production of Experimental Malignant Pleural Effusions Is Dependent on Invasion of the Pleura and Expression of Vascular Endothelial Growth Factor/Vascular Permeability Factor by Human Lung Cancer Cells

The American journal of pathology, 2000-12, Vol.157 (6), p.1893-1903

2000

Volltextzugriff (PDF)

Emerging therapies in non-small-cell lung cancer

Annals of oncology, 2001-06, Vol.12 (6), p.739-744

2001

Volltextzugriff (PDF)

Radionuclide Extraction by 2,6-Pyridinedicarboxylamide Derivatives and Chlorinated Cobalt Dicarbollide

Separation science and technology, 2006-06, Vol.41 (10), p.2111-2127

2006

Volltextzugriff (PDF)

The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials

Clinical radiology, 2021-02, Vol.76 (2), p.155.e25-155.e34

2021

Volltextzugriff (PDF)

Development and demonstration of solvent extraction processes for the separation of radionuclides from acidic radioactive waste

Waste management (Elmsford), 1999-01, Vol.19 (1), p.27-37

1999

Volltextzugriff (PDF)

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

Annals of oncology, 2018-04, Vol.29 (4), p.1072-1072

2018

Volltextzugriff (PDF)

Some aspects of fundamental chemistry of the Universal Extraction (UNEX) process for the simultaneous separation of major radionuclides (cesium, strontium, actinides, and lanthanides) from radioactive wastes

Journal of radioanalytical and nuclear chemistry, 2006-03, Vol.267 (3), p.603-613

2006

Volltextzugriff (PDF)

PEG-400 Partitioning in the HCCD/PEG Process for Cs and Sr Recovery

Separation science and technology, 2008-07, Vol.43 (9-10), p.2557-2571

2008

Volltextzugriff (PDF)

Long-term survival in patients (pts) with advanced NSCLC in the KEYNOTE-010 study overall and in pts who completed two years of pembrolizumab (pembro)

Annals of oncology, 2018-10, Vol.29, p.viii749-viii749

2018

Volltextzugriff (PDF)

1 – 25 von 3.205

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.740)
Mit Volltextzugriff
(2.649)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

Preoperative risk assessment does not allow to predict root filling length using machine learning: A longitudinal study

Innovative Clinical Trials: The LUNG-MAP Study

EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancer

A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer

Phase I trial of axitinib combined with platinum doublets in patients with advanced non-small cell lung cancer and other solid tumours

Phase I study of axitinib combined with paclitaxel, docetaxel or capecitabine in patients with advanced solid tumours

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial

Surrogate markers in antiangiogenesis clinical trials

Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function

Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis

Role of novel targeted therapies in the clinic

Production of Experimental Malignant Pleural Effusions Is Dependent on Invasion of the Pleura and Expression of Vascular Endothelial Growth Factor/Vascular Permeability Factor by Human Lung Cancer Cells

Emerging therapies in non-small-cell lung cancer

Radionuclide Extraction by 2,6-Pyridinedicarboxylamide Derivatives and Chlorinated Cobalt Dicarbollide

The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials

Development and demonstration of solvent extraction processes for the separation of radionuclides from acidic radioactive waste

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

Some aspects of fundamental chemistry of the Universal Extraction (UNEX) process for the simultaneous separation of major radionuclides (cesium, strontium, actinides, and lanthanides) from radioactive wastes

PEG-400 Partitioning in the HCCD/PEG Process for Cs and Sr Recovery

Long-term survival in patients (pts) with advanced NSCLC in the KEYNOTE-010 study overall and in pts who completed two years of pembrolizumab (pembro)

Suchergebnisse filtern